Johan Törlén - Concepedia

Author

Johan Törlén

Karolinska University Hospital ORCID

Also Known As

J Törlén, J. Törlen, Johan Karlsson Törlén, Johan Törlen, Johan Törlén

Publications

449

Citations

H-Index

Concepts

All Affiliations

Karolinska University Hospital Karolinska Institutet KTH Royal Institute of Technology University of Toronto Uppsala University Hospital

About

Johan Törlén is an author at Karolinska University Hospital specializing in cell transplantation, transplantation, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	124
2	Cellular Therapies	3	3	63
3	Health Sciences	2	2	33
4	Blood Transplantation	1	1	46
5	Epidemiology	1	1	18

Johan Törlén

Publications

433

Citations

H-Index

Page 1

	Year	Citations
Effect of Total Nucleated and CD34+ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation Mats Remberger, Johan Törlén, Olle Ringdén, Biology of Blood and Marrow Transplantation	2015	126
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation Johan Törlén, Olle Ringdén, Karin Garming-Legert, Haematologica	2016	70
Low CD34 Dose Is Associated with Poor Survival after Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome Johan Törlén, Olle Ringdén, Jennifer Le Rademacher, Biology of Blood and Marrow Transplantation Hematological MalignancyUnrelated DonorsTransplantationMarrow TransplantationMyelodysplastic Syndrome	2014	46
Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease Arwen Stikvoort, Yang Chen, Emelie Rådestad, Frontiers in Immunology Cgvhd SeverityCell TherapyImmunologyPathologyImmunophenotyping	2017	32
Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation Johan Törlén, Ahmed Gaballa, Mats Remberger, Biology of Blood and Marrow Transplantation	2019	24
Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients Lisa Swartling, Annika Allard, Johan Törlén, Transplant Infectious Disease	2015	19
Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation Ola Blennow, Mats Remberger, Johan Törlén, Biology of Blood and Marrow Transplantation Cell TherapyTransplantationBone Marrow FailureAntibioticsInvasive Mold Infections	2016	18
Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital Olle Ringdén, Mats Remberger, Johan Törlén, Pediatric Transplantation	2014	16
Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion Emelie Rådestad, Mikael Sundin, Johan Törlén, Frontiers in Immunology	2019	16
Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions Johan Törlén, Mats Remberger, Katarina Le Blanc, Biology of Blood and Marrow Transplantation	2017	15

Page 1